| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |